Jain-Hua Zhou

867 total citations
9 papers, 580 citations indexed

About

Jain-Hua Zhou is a scholar working on Surgery, Biotechnology and Genetics. According to data from OpenAlex, Jain-Hua Zhou has authored 9 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Biotechnology and 4 papers in Genetics. Recurrent topics in Jain-Hua Zhou's work include Bladder and Urothelial Cancer Treatments (6 papers), Cancer Research and Treatments (5 papers) and Cancer-related Molecular Pathways (3 papers). Jain-Hua Zhou is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Cancer Research and Treatments (5 papers) and Cancer-related Molecular Pathways (3 papers). Jain-Hua Zhou collaborates with scholars based in United States, Spain and Japan. Jain-Hua Zhou's co-authors include William F. Benedict, Shahrokh F. Shariat, Seth P. Lerner, Gustavo E. Ayala, Hideo Tokunaga, Charles J. Rosser, Robert Connor, Heidrun Engler, Daniel C. Maneval and Colin P. Dinney and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jain-Hua Zhou

9 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jain-Hua Zhou United States 9 393 201 164 101 81 9 580
David D. Wartinger United States 6 341 0.9× 223 1.1× 193 1.2× 94 0.9× 22 0.3× 7 543
Chietaka Ohmi Japan 12 220 0.6× 203 1.0× 102 0.6× 61 0.6× 30 0.4× 26 462
Timothy D. Jenkins United States 9 125 0.3× 227 1.1× 88 0.5× 108 1.1× 83 1.0× 10 415
Viola M. M. van Houten Netherlands 7 153 0.4× 176 0.9× 237 1.4× 60 0.6× 44 0.5× 7 580
MR Alison United Kingdom 9 190 0.5× 184 0.9× 155 0.9× 26 0.3× 50 0.6× 10 519
Mark Munsell United States 7 102 0.3× 190 0.9× 104 0.6× 9 0.1× 24 0.3× 12 432
U Ambus Canada 10 66 0.2× 61 0.3× 142 0.9× 57 0.6× 41 0.5× 26 343
Jane Ramsdale United Kingdom 6 73 0.2× 237 1.2× 183 1.1× 35 0.3× 56 0.7× 8 436
Emile Trahan United States 8 55 0.1× 146 0.7× 112 0.7× 101 1.0× 22 0.3× 8 375
Orla M. Gannon Australia 11 48 0.1× 277 1.4× 127 0.8× 41 0.4× 21 0.3× 11 481

Countries citing papers authored by Jain-Hua Zhou

Since Specialization
Citations

This map shows the geographic impact of Jain-Hua Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jain-Hua Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jain-Hua Zhou more than expected).

Fields of papers citing papers by Jain-Hua Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jain-Hua Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jain-Hua Zhou. The network helps show where Jain-Hua Zhou may publish in the future.

Co-authorship network of co-authors of Jain-Hua Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jain-Hua Zhou. A scholar is included among the top collaborators of Jain-Hua Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jain-Hua Zhou. Jain-Hua Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kim, Mi Sook, Joon Jeong, Tadeusz Majewski, et al.. (2006). Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia. Laboratory Investigation. 86(2). 175–190. 13 indexed citations
2.
Benedict, William F., Changsoo Kim, Xinqiao Zhang, et al.. (2004). Intravesical Ad-IFNα Causes Marked Regression of Human Bladder Cancer Growing Orthotopically in Nude Mice and Overcomes Resistance to IFN-α Protein. Molecular Therapy. 10(3). 525–532. 76 indexed citations
3.
Shariat, Shahrokh F., Hideo Tokunaga, Jain-Hua Zhou, et al.. (2004). p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer. Journal of Clinical Oncology. 22(6). 1014–1024. 255 indexed citations
4.
Gee, Jason, et al.. (2003). Noninvasive Detection of Bladder Cancer in an Orthotopic Murine Model With Green Fluorescence Protein Cytology. The Journal of Urology. 170(3). 975–978. 18 indexed citations
5.
Shariat, Shahrokh F., Kazumasa Matsumoto, Gustavo E. Ayala, et al.. (2003). Correlation of Cyclooxygenase-2 Expression With Molecular Markers, Pathological Features and Clinical Outcome of Transitional Cell Carcinoma of the Bladder. The Journal of Urology. 170(3). 985–989. 53 indexed citations
6.
Zhou, Jain-Hua, Charles J. Rosser, Motoyoshi Tanaka, et al.. (2002). Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression. Cancer Gene Therapy. 9(8). 681–686. 25 indexed citations
7.
Rosser, Charles J., Jain-Hua Zhou, Robert Connor, et al.. (2002). Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer. Cancer Gene Therapy. 9(8). 687–691. 57 indexed citations
8.
Tokunaga, Hideo, Shahrokh F. Shariat, R. Malcolm Brown, et al.. (2001). Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens. International Journal of Radiation Oncology*Biology*Physics. 51(1). 16–22. 23 indexed citations
9.
El‐Naggar, Adel K., Syeling Lai, Gary L. Clayman, et al.. (1999). Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: Biological and clinical implications. Human Pathology. 30(9). 1013–1018. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026